期刊文献+

口服^(99)T_c^m-DTPA检测胆石症患者肠黏膜通透性 被引量:3

Determination of intestinal permeability in cholelithiasis patients by oral administration of technetium-99 m-diethylenetriaminepentaacetatic acid
原文传递
导出
摘要 目的比较不同类型胆石症患者与正常人肠道黏膜通透性的差异。方法根据术中结石剖面结构,将56例胆石症患者分为胆固醇结石组(n=15)和胆色素结石组(n=41),17例健康志愿者作为对照组,采用口服 ^(99)T_c^m-DTPA 的方法比较3组24 h 尿液中^(99)T_c^m-DTPA 排泄率,即肠道黏膜通透性。结果对照组24 h 尿液中^(99)T_c^m-DTPA 排泄率为4.5%±3.4%,胆固醇结石组5.0%±3.6%,胆色素结石组10.5%±6.9%,胆色素结石组尿液^(99)T_c^m-DTPA 排泄率明显高于对照组(F 值7.62,P<0.05),但胆固醇结石组与对照组比较,差异无统计学意义(F 值2.16,P>0.05)。结论胆色素结石患者肠黏膜通透性显著高于对照组,肠黏膜通透性增加可能是胆色素结石的一个发病原因。 Objective To investigate the intestinal permeability of patients with cholelithiasis of different types. Methods Technetium-99m-diethylenetriaminepentaacetatic acid (^99mTc- DTPA) at the dose of 185 MBq (5 mCi) was administered orally to 56 patients of cholelithiasis, 15 cases of cholesterol stone ( CS group ) and 41 cases of pigment stone ( PS group) based on the cross section of the stone during operation, and 17 healthy controls. A 24 h urine collection was obtained after the ingestion of the tracer to calculate the urinary excretion of DTPA. Results The mean percentage of the total ingested dose of ^99mTc- DTPA excreted in a 24 h urinary excretion was 5.0% ± 3.6% in the CS group, not significantly different from that in the control group (4. 5% ± 3.4%. F = 2. 18 ,P 〉 0.05 ), and the mean percentage of the total ingested dose of ^99mTc- DTPA excreted in a 24 h urinary excretion of the PS group was 10. 5% ± 6. 9%, significantly higher than that in the control group (F =7.62,P 〈0. 05), showing a significantly increase of intestinal permeability( P 〈 0. 05 ). Conclusion The intestinal permeability of the patients of pigment stone is higher than that of the healthy subjects. Hyperpermeability may be a factor of the pathogenesis of pigment stone.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第7期464-467,共4页 National Medical Journal of China
关键词 胆结石 毛细血管通透性 ^99TC^M Cholelithiasis Capillary permeability Technetium Tc 99m pentetate
  • 相关文献

参考文献13

二级参考文献30

  • 1汤文浩,韩天权,张圣道.胆囊结石患者的血清脂质研究[J].中国病理生理杂志,1995,11(2):170-173. 被引量:6
  • 2顾牛范,冯国鄞,江三多,钱伊萍,林嗣萃,吴晓东,任大明,江开达.中国汉族人群APOE等位基因频率的初步研究[J].中华医学遗传学杂志,1996,13(1):8-10. 被引量:26
  • 3Ye P,Atherosclerosis,1995年,117卷,43页
  • 4Everhart JE, Khare M, Hill M, et al. Prevalence and ethic differences in gallbladder disease in the United States.Gastroenterology, 1999, 117:632-639.
  • 5李立明.流行病学第5版[M].北京:人民卫生出版社,2004.320-325.
  • 6Kratzer W, Mason RA, Kachele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound, 1999, 27 : 1-7.
  • 7Barbara L, Sama C, Morselli Labate AM, et al. A population study on the prevalence of gallstone disease: the Sirmione study.Hepatology, 1987, 7:913-917.
  • 8Friedman GD, Kannel WB, Dawber TR. The epidemiology of gallbladder disease:observations in the Framingham study. J Chronic Dis, 1966, 19:273-292.
  • 9Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian study on epidemiology of cholelithiasis. Hepatology, 1997, 26:809-818.
  • 10Carey MC, Small DM. The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man. J Clin Invest, 1978, 61:998-1026.

共引文献41

同被引文献18

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部